51/100BAxon Enterprise stock forecast 2026–2030What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Axon Enterprise is 612.56, 101.8% above the current price of 303.62. Their targets range from 500.00 to 715.00.
Of the 11 firms that rated Axon Enterprise in the past 12 months, 10 rate it buy or strong buy, 1 hold and 0 sell or strong sell (each firm at its latest rating): a Strong buy consensus.
Analysts' 1-year price targets range from 500.00 to 715.00, with an average of 612.56.
| Buy | 10 | |
| Hold | 1 | |
| Sell | 0 |
12-month price target
| Highest target | 715.00 |
| Average target | 612.56 |
| Lowest target | 500.00 |
| Current price | 303.62 |
Axon Enterprise price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Axon Enterprise price target and rating?
How analysts rate Axon Enterprise, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
10 of 11 firms rate it buy now, against 12 of 13 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Axon Enterprise analyst upgrades, downgrades and price targets
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 6 Nov 2026 | Northland Securities Michael Latimore | — | 540.00 | — | 312.66 |
| 6 Nov 2026 | RBC Capital David Paige | Reiterated · Outperform | 735.00 → 615.00 | -16.3% | 316.64 |
| 6 Nov 2026 | Piper Sandler James Fish | Reiterated · Overweight | 561.00 → 540.00 | -3.7% | 314.49 |
| 6 Nov 2026 | Needham Joshua Reilly | Reiterated · Buy | 750.00 → 500.00 | -33.3% | 382.56 |
| 20 Oct 2026 | Piper Sandler | Reiterated · Overweight | 732.00 → 561.00 | -23.4% | 383.09 |
| 15 Oct 2026 | Raymond James | — | 675.00 | — | 402.87 |
| 3 Sept 2026 | Argus Research | Reiterated · Buy | 600.00 | — | 506.98 |
| 6 Aug 2026 | Morgan Stanley Meta Marshall | Reiterated · Overweight | 600.00 → 640.00 | +6.7% | 528.41 |
| 6 Aug 2026 | Goldman Sachs | — | 535.00 → 715.00 | +33.6% | 561.47 |
| 6 Aug 2026 | Piper Sandler | Reiterated · Overweight | 724.00 → 732.00 | +1.1% | 551.40 |
| 6 Aug 2026 | Barclays | Reiterated · Overweight | 523.00 → 688.00 | +31.5% | 609.49 |
| 13 Jul 2026 | Piper Sandler | Reiterated · Overweight | 674.00 → 724.00 | +7.4% | 565.80 |
| 6 Jul 2026 | Needham | Reiterated · Buy | 870.00 → 750.00 | -13.8% | 597.04 |
| 15 Jun 2026 | Piper Sandler James Fish | — | 690.00 → 674.00 | -2.3% | 457.33 |
| 8 May 2026 | Barclays Tim Long | Reiterated · Overweight | 523.00 | — | 426.89 |
| 7 May 2026 | Morgan Stanley | — | 675.00 → 600.00 | -11.1% | 433.82 |
| 7 May 2026 | Goldman Sachs | — | 625.00 → 535.00 | -14.4% | 434.50 |
| 7 May 2026 | UBS | Reiterated · Neutral | 840.00 → 440.00 | -47.6% | 416.57 |
| 8 Apr 2026 | Morgan Stanley | — | 713.00 → 675.00 | -5.3% | 391.53 |
| 8 Apr 2026 | Goldman Sachs | Reiterated · Buy | 625.00 | — | 391.53 |
| 25 Feb 2026 | Robert W. Baird | — | 800.00 | — | 523.63 |
| 25 Feb 2026 | Craig-Hallum Jeremy Hamblin | — | 900.00 → 820.00 | -8.9% | 543.47 |
| 25 Feb 2026 | RBC Capital David Paige | Reiterated · Outperform | 860.00 → 735.00 | -14.5% | 543.24 |
| 25 Feb 2026 | Piper Sandler James Fish | Reiterated · Overweight | 753.00 → 690.00 | -8.4% | 548.23 |
| 6 Jan 2026 | Northcoast Research Keith Housum | — | 742.00 | — | 591.16 |
| 17 Dec 2025 | Morgan Stanley Meta Marshall | Reiterated · Overweight | 885.00 → 713.00 | -19.4% | 555.06 |
| 17 Nov 2025 | RBC Capital | — | 860.00 | — | 554.37 |
Axon Enterprise EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Analysts expect Axon Enterprise's EPS to grow 103.0% a year until 2028.
Analysts expect Axon Enterprise's revenue to grow 27.9% a year until 2028, slower than over the last 5 years (32.5% a year) and the last 3 years (32.7%).
Revenue
EPS
Does Axon Enterprise beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 22.4% off the result, either way, and their revenue estimate 3.4%, over the last 12 quarters.
- EPS beats
- 57 / 79
- Revenue beats
- 22 / 24
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +17.1%
- Since
- February 2004
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 5 Nov 2026 | 1.89 | 1.72 | -9.0% | 934.33M | 908.55M | -2.8% |
| Q2 FY2026 | 5 Aug 2026 | 1.84 | 1.88 | +2.2% | 876.42M | 904.39M | +3.2% |
| Q1 FY2026 | 6 May 2026 | 1.60 | 1.61 | +0.6% | 780.66M | 807.35M | +3.4% |
| Q4 FY2025 | 24 Feb 2026 | 1.60 | 2.15 | +34.4% | 755.56M | 796.72M | +5.4% |
| Q3 FY2025 | 4 Nov 2025 | 1.52 | 1.17 | -23.0% | 704.84M | 710.64M | +0.8% |
| Q2 FY2025 | 4 Aug 2025 | 1.45 | 2.12 | +46.2% | 641.02M | 668.54M | +4.3% |
| Q1 FY2025 | 7 May 2025 | 1.27 | 1.41 | +11.0% | 586.39M | 603.63M | +2.9% |
| Q4 FY2024 | 25 Feb 2025 | 1.37 | 2.08 | +51.8% | 566.01M | 575.15M | +1.6% |
| Q3 FY2024 | 7 Nov 2024 | 1.20 | 1.45 | +20.8% | 525.34M | 544.27M | +3.6% |
| Q2 FY2024 | 6 Aug 2024 | 1.02 | 1.20 | +17.6% | 478.35M | 504.10M | +5.4% |
| Q1 FY2024 | 6 May 2024 | 0.95 | 1.15 | +21.7% | 441.56M | 460.74M | +4.3% |
| Q4 FY2023 | 27 Feb 2024 | 0.86 | 1.12 | +30.2% | 420.95M | 432.14M | +2.7% |
Axon Enterprise stock price 2026–2030: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If Axon Enterprise's earnings grow at the 22.6% a year analysts expect to FY2028, then 15.0% a year, it would earn about 16.71 a share in FY2030. At the P/E of similar companies (Aerospace & Defense, 26.6 to 41.0) that is 445.29 to 684.93 a share, or 546.12 at their average P/E of 32.7. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 7.19 | 191.54 | 234.92 | 294.63 |
| FY2027 | 9.44 | 251.53 | 308.49 | 386.90 |
| FY2028 | 12.64 | 336.70 | 412.94 | 517.91 |
| FY2029 (extrapolated) | 14.53 | 387.21 | 474.89 | 595.59 |
| FY2030 (extrapolated) | 16.71 | 445.29 | 546.12 | 684.93 |
Each year's EPS is the analysts' consensus to FY2028; the years after grow 15.0% a year (the analysts' growth, at most 15%). Its own P/E has been above 60, or from losses, too often in the last five years, so bear, base and bull apply the lowest, average and highest P/E of similar companies (Aerospace & Defense: 26.6, 32.7, 41.0), those up to 60.
Is Axon Enterprise stock undervalued or overvalued?How does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
Axon Enterprise's P/E of 94.6 is near the bottom of its 5-year range (54.8 to 359.4, median 154.0). Analysts do not expect slower growth than in recent years, so it is cheaper than its usual level. Fair value is not a reliable guide for Axon Enterprise: it made a loss in FY2021, so its usual P/E says little about what it is worth. Its forward P/E, on the consensus for FY2026, is 42.2.
- Price to earnings ratio (TTM)What is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 94.59
- Five-year median P/EWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 153.97
- Five-year P/E range
- 54.8 – 359.4
- Forward P/E (FY2026)What is the forward P/E ratio? Forward P/E divides a share's price by the earnings per share analysts expect in the coming year, rather than last year's actual earnings.
- 42.23
- PEG ratioWhat is the PEG ratio? The PEG ratio divides the P/E by the yearly earnings growth analysts expect, to show how much you pay for each point of growth.
- 4.18
- To the average targetWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
- +101.8%
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 35.850 | 71.4258Price 35.85193 | +99.2% | |
| 29.050 | 56.2634Price 29.0596 | +93.7% | |
| 241.000 | 464.49205Price 241.00627 | +92.7% | |
| 123.590 | 237.24178Price 123.59297 | +92.0% | |
| 161.400 | 305.52159Price 161.40396 | +89.3% | |
| 157.460 | 297.58169Price 157.46471 | +89.0% | |
| 217.560 | 405.38304Price 217.56507 | +86.3% |
Furthest below the fair value on each stock's page, updated every day.